Position in NBIX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$52,724,705
+$12,699,459 QoQ
Shares Held
312,832
+3.0% QoQ
Ownership
0.308%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#60
of 768 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 51%
Shared 0%
None 49%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $455,921,156 across 48 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (11.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,437,213 | $103,278,126 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
120,078 | $65,061,862 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
This page
|
312,832 | $52,724,705 | |
| 4 | VTRS |
Viatris Inc
|
2,872,464 | $45,614,728 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
1,264,159 | $31,110,952 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
633,778 | $21,973,083 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
197,060 | $21,861,836 | |
| 8 | ALKS |
Alkermes plc.
|
387,999 | $20,331,147 |
All Filings in NBIX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $52,724,705 | 312,832 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $40,025,246 | 303,820 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $42,186,482 | 297,444 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $42,606,733 | 303,510 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $38,862,091 | 309,190 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $34,782,151 | 314,486 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $43,745,247 | 320,478 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $37,071,689 | 321,747 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $44,644,728 | 324,288 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $44,424,997 | 322,107 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $42,020,899 | 318,920 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $36,620,212 | 325,513 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $30,959,350 | 328,307 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $31,033,444 | 306,594 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $35,831,761 | 299,998 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $30,530,064 | 287,450 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $27,141,843 | 278,435 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $23,931,000 | 255,264 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $21,709,833 | 254,900 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $24,079,452 | 251,063 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $24,523,569 | 251,989 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $24,717,157 | 254,161 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $10,891,339 | 113,629 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $11,532,372 | 119,929 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $15,589,282 | 127,781 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $8,694,639 | 100,458 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||